Firefly Neuroscience, Inc.
AIFF
$3.20
-$0.01-0.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 60.61% | 230.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 60.61% | 230.00% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 60.61% | 230.00% | |||
| SG&A Expenses | -36.37% | 272.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -39.20% | 238.93% | |||
| Operating Income | 39.97% | -239.00% | |||
| Income Before Tax | 11.80% | -239.32% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 11.75% | -239.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.75% | -239.32% | |||
| EBIT | 39.97% | -239.00% | |||
| EBITDA | 40.01% | -239.22% | |||
| EPS Basic | 28.20% | -2,294.07% | |||
| Normalized Basic EPS | 45.06% | -2,296.20% | |||
| EPS Diluted | 28.20% | -2,294.07% | |||
| Normalized Diluted EPS | 45.06% | -2,296.20% | |||
| Average Basic Shares Outstanding | 22.91% | -85.82% | |||
| Average Diluted Shares Outstanding | 22.91% | -85.82% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||